ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,636Medicare Part D Prescriptions Filled, Including Refills

Rank: 48 out of 978

$602K Total Retail Price of All Prescriptions

Rank: 25 out of 978

298 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 298 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

6% of this provider’s 298 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 7,452 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
SIMVASTATIN 449 375 1 2
LISINOPRIL 403 376 2 1
ATORVASTATIN CALCIUM 341 331 3 12
ATENOLOL 328 316 4 8
LEVOTHYROXINE SODIUM 319 305 5 4
METOPROLOL TARTRATE 215 162 6 10
FUROSEMIDE 209 204 7 9
HYDROCHLOROTHIAZIDE 204 193 8 5
AMLODIPINE BESYLATE 197 185 9 6
WARFARIN SODIUM 193 193 10 11
CRESTOR 184 153 11 30
LISINOPRIL-HYDROCHLOROTHIAZIDE 163 141 12 36
PRAVASTATIN SODIUM 145 131 13 16
METOPROLOL SUCCINATE 143 121 14 13
OMEPRAZOLE 136 96 15 3
LOSARTAN POTASSIUM 134 120 16 22
TAMSULOSIN HCL 123 103 17 33
DIOVAN 104 95 18 43
FLUTICASONE PROPIONATE 101 77 19 28
KLOR-CON M20 91 74 20 66
METFORMIN HCL 89 73 21 7
PROAIR HFA 89 66 21 19
SYNTHROID 88 85 23 125
SPIRIVA 82 74 24 37
DIOVAN HCT 80 80 25 154
ADVAIR DISKUS 80 70 25 35
LORAZEPAM 76 75 27 74
GLIPIZIDE ER 76 64 27 103
AMLODIPINE BESYLATE-BENAZEPRIL 74 64 29 173
METFORMIN HCL ER 73 60 30 48
LOSARTAN-HYDROCHLOROTHIAZIDE 67 45 31 122
LANTUS SOLOSTAR 67 54 31 143
GABAPENTIN 64 41 33 15
SERTRALINE HCL 63 57 34 21
CARVEDILOL 60 60 35 55
DILTIAZEM 24HR ER 59 52 36 69
ZOLPIDEM TARTRATE 56 45 37 32
AVODART 55 55 38 266
CYMBALTA 54 43 39 60
NAMENDA 52 52 40 45
DEXILANT 52 22 40 104
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.